2009;114:1150-7. SELLAS Life Sciences Group Galinpepimut -S Protocol : SLS17 -201/ MK3475 -770 Protocol v1.1 (Amendment 1.0) 12 April 2019 Page 244 Lawson DH, Lee S, Zhao F, et al. Randomized, placebo -controlled, phase III trial of yeast- derived granulocyte-macrophage colony-stimulating factor (GM-CSF) versus peptide vaccination versus GM-CSF plus peptide vaccination versus placebo in patients with no evidence of disease after complete surgical resection of locally advanced and/or stage IV melanoma: a trial of the Eastern Cooperative Oncology Group -American College of Radiology Imaging Network Cancer Research Group (E4697). J Clin Oncol.